A deal that would see a fresh shot of capital injected into MDMA drug developer Lykos Therapeutics is nearing completion, with insiders saying the first phase of the deal could close any day soon. According to information obtained by Psychedelic Alpha, the initial $50 million tranche will be split evenly between Elon Musk ally Antonio Gracias and ‘Europe’s most feared…
